Enlivex Share Price
NASDAQ: ENLV | Healthcare$1.20
+$0.05 (4.80%) Last updated on 19 Nov, 2026 | 02:29 ISTEnlivex Stock Performance
Enlivex Share Price Chart
$0.00$0.00
L
H
Enlivex Annual Profit & Loss
All figures in USD
Enlivex Balance Sheet
All figures in USD Million
Enlivex Cash Flow
Annually
All figures in USD Million
Corporate Actions
About Enlivex
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Enlivex Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.49 | $1.15 | -36.39% |
Oct 2026 | $0.44 | $1.80 | +253.63% |
Sep 2026 | $1.27 | $0.51 | -65.61% |
Aug 2026 | $2.17 | $1.48 | -27.45% |
Jul 2026 | $0.53 | $2.04 | +271.58% |
Jun 2026 | $0.78 | $0.55 | -33.05% |
May 2026 | $0.83 | $0.82 | -0.24% |
Apr 2026 | $0.98 | $0.82 | -11.71% |
Mar 2026 | $1.12 | $0.93 | -19.04% |
Feb 2026 | $1.01 | $1.15 | +13.41% |
Jan 2026 | $0.73 | $1.01 | +41.42% |
Dec 2025 | $0.93 | $0.72 | -26.01% |